The Medical Supply Authority received a fresh consignment of Novoseven on Monday evening, a specialised drug manufactured by Danish pharmaceutical company Novo Nordisk and used primarily to control bleeding. The delivery forms part of the national procurement programme aimed at securing both general and specialised medications for hospitals and health centres across the country.
According to the Authority, the shipment will be distributed in line with the approved plan, following inspection and quality verification procedures carried out by the Food and Drug Control Centre to ensure timely delivery to designated facilities.
This step is part of broader efforts to reinforce Libya’s strategic stockpile of medical supplies and maintain consistent, high-quality healthcare services for citizens nationwide.